News

Celadon Pharmaceuticals Reaffirms Commitment to Patient Centred Innovation in Cannabis Based Medicines

  • by

Celadon Pharmaceuticals reaffirms its patient-centred approach, advancing cannabis-based medicines through innovation, regulatory excellence, and MHRA-licensed research. Focused on limited-treatment conditions, the UK company aims to deliver safe, effective, evidence-based therapies that improve patients’ quality of… Read More »Celadon Pharmaceuticals Reaffirms Commitment to Patient Centred Innovation in Cannabis Based Medicines